About CRI

Glenn Dranoff, M.D.

Image

Dana-Farber Cancer Institute
Boston, MA

Glenn Dranoff, M.D., is a professor of medicine at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Harvard Medical School. Dr. Dranoff is the leader of the Dana-Farber/Harvard Cancer Center Program in Cancer Immunology, co-leader of the Dana-Farber Cancer Institute Cancer Vaccine Center, and director of Dana-Farber Human Gene Transfer Laboratory, and the principal investigator of the CRI-funded Harvard Immunology Training Grant for Predoctoral Students in Cancer Immunology. He is an associate director of the Cancer Research Institute Scientific Advisory Council and a member of the Academy of Cancer Immunology, the American Society of Clinical Investigation, the European Academy of Tumor Immunology, and the Osler Interurban Clinical Club. He is also the editor-in-chief of Cancer Immunology Research, a scientific journal published by the American Association for Cancer Rsearch (AACR), in collaboration with the Cancer Research Institute.

Dr. Dranoff received his B.S. from Duke University and his M.D. from Duke University School of Medicine. He completed an internship and residency in internal medicine at Massachusetts General Hospital and a clinical fellowship in medical oncology at DFCI. He received postdoctoral training at the Whitehead Institute. His research focuses on understanding the molecular and cellular mechanisms underlying the stimulation of antitumor immunity, and on the development of cancer vaccines.